SEC Form 4 · accession 0001209191-15-068288
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay M Moyes
Director
Period of report
Aug 26, 2015
Accepted (ET)
Aug 27, 2015 · 6:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401667
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $86.43 | Aug 26, 2015 | A | 20,000 | A | — | Aug 25, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The vesting commencement date ("VCD") of the option is August 26, 2015. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the VCD and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the VCD thereafter, subject to the Reporting Person's continued service through each vesting date as chair of the Audit Committee of the Board of Directors of the Issuer.